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Objectives: There has been a parallel increase in the incidence of obesity and diabetes as well as the
number of daily meals. However, evidence is lacking regarding the role of intermittent fasting. The
aim of this study was to determine the effects of a Ramadan model of intermittent fasting (RIF; 14 h
of daytime abstinence from food and drinking) for 28 d on body composition, glucose metabolism,
and cognitive function.
Methods: Ten healthy, lean men were included in a nonrandomized, crossover, intervention study.
Testing was performed before a control period of 28 d, as well as before and after 28 d of RIF.
Whole-body dual-energy x-ray absorptiometry, magnetic resonance imaging of the abdomen,
ﬁtness test, oral glucose tolerance test, and cognitive function tests were performed. As secondary
outcome, the participants’ physical activity and 72-h glycemic responses were monitored 6 d
within each of the periods. Dietary intake, appetite, and mood questionnaires also were assessed.
Results: Comparing D differences from testing days; body mass index changes from the control period
(D mean: 0.2 kg/m2, 95% conﬁdence interval [CI], 2 to 0.5) and the RIF period (D mean: 0.3 kg/m2,
95% CI,0.6 to0.1) were signiﬁcantly different (P < 0.05). Secondary outcomes within the RIF period
showed an increased area under curve (AUC) for hunger accompanied by a reduced AUC for satiety
(both, P< 0.05), less mean steps per day (P< 0.05), and less positive feelings in the afternoon (P< 0.01)
compared with the control period. No changes were observed in any of the other evaluated parameters.
Conclusions: Free-living participants were able to comply with 14 h of daily daytime abstinence
from food and drinking for 28 d with only a minor effect on body mass index and without any
effects on body composition, glucose metabolism, and cognitive function.
 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
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Obesity, a major global health threat, is caused by a chronic
imbalance between energy intake and utilization, and is affected
by a number of factors [1]. Among these factors, which include
reduced physical activity and intake of energy-dense foods, the
number of meals per day may play a fundamental role by
inﬂuencing our sense of satiety and overall caloric intake [2,3].
There is limited scientiﬁc research regarding the optimal
number of daily meals and the studies that do exist reach
opposing conclusions [4–6]. The Danish Health Authority
recommends eating three main meals and several small meals
per day as part of a healthy lifestyle with the aim of improving
control of blood lipids among others [7].
In contrast, an increase in the typical number of daily meals
has been paralleled by an increase in the incidence of obesity and
diabetes throughout recent decades [8]. One important argument
against increased meal frequency is that people tend to increase
energy intake per meal, generally in the form of foods with high
sugar and fat content [2,9]. In the Nordic countries, for instance,
snacking comprises almost 30% of the total daily energy intake [5].
In this context, recent studies suggest that intermittent fasting
(IF) has beneﬁcial effects on health [9–11]. In lower eukaryotes,
chronic fasting extends longevity partly by reprogramming
metabolic and stress resistance pathways [10]. IF in rodents
protects against diabetes, cancer, heart disease, and neuro-
degeneration. There are some discrepancies among studies with
regard to the clinical beneﬁts of IF [10,12]. However, in humans it
has been reported that IF may reduce hypertension [13,14],
asthma [15,16], and rheumatoid arthritis [17], as well as body
weight in obese individuals [10,18,19].
Thus, the increasing interest for IF as a dietary strategy
represents a potentially attractive alternative to the dogma of
high meal frequency as a pathway to health. However, studies
that analyzed the health effects of IF on humans in free-living
lean participants have identiﬁed varied outcomes, potentially
due to a wide range of research designs [20,21].
Millions of people undertake 1 mo of IF in observance of the
Islamic Ramadan, where fasting takes place during daylight hours
from dawn to sunset. In countries near the north and south poles,
the fast can last up to 22 h. However, people in these areas are
allowed to assimilate the fast period of Mecca [22], where the
longest fasting period is w14 h, depending on the season. Thus,
this reoccurring fasting model may constitute an interesting
model for studying IF.
Although some studies, including a meta-analysis [23],
suggest that IF during Ramadan may lower body weight, fasting
blood glucose, and cholesterol levels in men [24,25], other
studies have reached directly opposing study results, e.g., the
Ramadan fasting is associated with the following:
 Impaired insulin sensitivity and an increase in the adipokine
adiponectin [26];
 Improved insulin sensitivity and a decrease in adiponectin
[27]; or
 Impaired insulin sensitivity and a decrease in adiponectin
[28].
Moreover, a few studies have shown that the Ramadan
increased the number of trafﬁc accidents and resulted in a bad
mood, slowed reaction time, poormemory, andwork performance,
as well as increased irritability [29–31].
Although these studies provide valuable data, they have not
accounted for confounders like altered sleep–wake cycle, culturalhabits, physical activity, and changes in food intake [32,33].
Therefore, the present study, inspired by the Ramadan IF, is, to
our knowledge, the ﬁrst to assess in both a systematic and
controlled setting, the independent effects of 14 h of IF, which we
called the Ramadan model of IF (RIF), for 28 d on metabolic
parameters and cognitive function in free-living healthy lean
men. The objectives of this study were to explore differences
between the RIF period and an ad libitum control period on body
composition, glucose metabolism, or cognitive functions.
Methods
Participants and the study design
Obtaining consent from study participants
Participants were given both oral and written information about the study
before signing a consent form. The study followed the guidelines from the
Helsinki Declaration, and was approved by the Danish Ethics Committee of the
Capital Region (record number H-3-2011-023), and registered at the Danish Data
Protection Agency (record number 2007-58-0015).
Study participants were recruited by means of advertisement in newspapers
and via the Internet. Recruitment began in July 2011 and the last follow-up
measurements for the 10 participants were completed by June 2012. None of
the control or RIF periods was performed during July (summer holiday) or
December (Christmas holiday).
Screening
Study participants were their own controls, and were considered eligible if,
after3dofmonitoring (includinganassessmentofphysical activity, heart rate, and
diet), they met the following inclusion criteria: ages 18 to 35 y, body mass index
(BMI) between 18 and 25 kg/m2, a normal medical examination and blood screen,
typically consumed three to sixmeals a day, andwere physically active (i.e., taking
>8000 steps/d). Exclusion criteria were female sex (to avoid menstrual cycle
effects), use of any kind of daily medications, presence of any chronic diseases,
alcohol abuse or consumption of more than 14 units of alcohol per week, tobacco
smoking (including occasional smoking), and not being of western European
descent (to avoid inﬂuence on glucose metabolism in a small study group [34]).
Study design
Participants underwent an 8-wk study consisting of two consecutive periods:
a 4-wk control period followed by a 4-wk RIF period. In this nonrandomized,
crossover, intervention study the participants were used as their own controls.
They were not randomized due to biases such as weight loss and altered bene-
ﬁcial eating habits by fasting before the control period. During the control period,
each participant maintained his usual eating and exercise habits. During the RIF
period, participants abstained from eating and drinking any ﬂuids for 14 h
consecutively during daylight hours for 28 d consecutively. Participants were
asked to register any break of the fast by date and time. Outside the fasting
period, participants were allowed to eat and drink ad libitum (two meals).
Before and after both the control and RIF periods, participants underwent
three test modules: before the control period (BCP), after the control period
(ACP), and after the RIF period (AIF; Fig. 1) each lasting 2 d with 28 d between.
The test modules at time points BCP, ACP, and AIF comprised of weight
measurements and blood pressure, 3-h oral glucose tolerance test (OGTT),
maximal oxygen intake (VO2 max) ﬁtness test, cognitive testing, and a whole-
body dual-energy x-ray absorptiometry (DXA) scan. Testing was performed
after a 12-h overnight fast at the Centre of Inﬂammation and Metabolism/The
Centre for Physical Activity Research Rigshospitalet, Denmark. Participants also
underwent magnetic resonance imaging (MRI) scans at time points ACP and AIF
at Rigshospitalet, Denmark. Additionally, during 3 d at the beginning (T1 and T3)
and 3 d at the end (T2 and T4) of the control and RIF periods, participants were
assessed for habitual energy expenditure using the Actiheart accelerometer
(Cambridge Neurotechnology Ltd, Cambridge, UK), daily steps using a pedometer
(Yamax Digi-walker CW-300 pedometer), 72-h glucose proﬁle using the
Continuous Glucose Monitoring System (Medtronic Diabetes Inc, Northridge, CA,
USA), dietary intake, appetite, and mood.
Tests from BCP, ACP, and AIF period study days (D difference measurements)
Anthropometric assessment
Weight wasmeasured to the nearest 0.1 kg on an electronic scale (Bisco scales,
Farum, Denmark), with participants dressed in underwear. Height was measured
to the nearest 0.5 cm using a portable stadiometer (HR 001, Tanita Leicester
Portable Height Measure, Tokyo, Japan). BMI was calculated as weight (kg)/height
(m)2. Waist and hip circumferences were measured to the nearest 0.5 cm; waist
circumference was deﬁned as the midline between the lowest border of rib cage
RIF PERIOD:
-Total abstinence from food and drinking for 14 
consecutive daytime hours for 28 d
Anthropometry
OGTT
Fitness test
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DXA scan
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SCREENING:
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Fig. 1. Overview of the study design. Participants acted as their own control in a nonrandomized, crossover, intervention design consisting of two consecutive periods: A
4-wk control period followed by a 4-wk Ramadan model of intermittent fasting (RIF) period. Arrows indicate day of testing. T1 and T2 are monitoring periods within the
control period, and T3 and T4 are monitoring periods within the RIF period. ACP, after the control period; AIF, after the intermittent fasting period; BCP, before the control
period; CGMS, continuous glucose monitoring system; CFAS, Centre for Physical Activity Research; CIM, Centre of Inﬂammation and Metabolism; DXA, dual-energy x-ray
absorptiometry; OGTT, oral glucose tolerance test; Actiheart, Actiheart accelerometer monitoring system. *For logistical reasons, magnetic resonance imaging (MRI) scan was
only measured before and after the intermittent fasting period.
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hips while the participant was standing, as previously described [35].
Body composition measured by DXA and MRI scans
Total and regional muscle and fat mass of the body was measured using a
DXA scan (Lunar Prodigy Advance, GEMedical systems, Milwaukee, WI, USA). For
logistical reasons, participants were only scanned twice by 3-Tesla MRI scan
(Siemens Magnetom Total imaging matrix magnetic resonance scanner,
Erlangen, Germany). The scans were before and after the RIF period from the top
of the diaphragm to the pelvic ﬂoor. The visceral fat was then double-blinded and
manually plotted (on computer using MANGO software version 2.5, University of
Texas Health Science Center, San Antonio, TX, USA) on each of the T1-weighted
axial images, and volume in mL calculated as the sum of all images.
Standardized OGTT
Participants were asked to register their diet the evenings before the ﬁrst and
second study day of BCP, and subsequently eat exactly the same diet the two
evenings before the study days of ACP, and of AIF, respectively. One intravenous
catheterwas placed in the anterior cubital region after a 12-h overnight fast. After
the venous blood baseline samples were drawn, the participant drank a glucose
solution consisting of 75 g of glucose (water-free) dissolved in 300 mL of water,
and continued to rest for 3-h while 3 mL of blood was drawn every 20 min.
Plasma samples were collected in EDTA-containing tubes and immediately
centrifuged for 15min at 3500g, and the plasmawas stored at80C until further
analysis. Serum samples were collected in serum collector tubes and placed
upright at room temperature for 20 to 40min before being centrifuged for 15min
at 3500g and stored at 80C until further analysis.
Matsuda insulin sensitivity index and homeostasis model assessment-estimated
insulin resistance (HOMA-IR) index were calculated as previously described [35].
Cognitive function testing
Participants underwent a battery of neuropsychological tests for memory,
executive functions, and attention. A habituation test was performed on the
screening day. The testing was performed under optimal conditions (i.e., appro-
priate lighting, silence, and isolation from unnecessary stimuli). The test battery
was comprised of following validated tests: the Trail Making Test A and B [36],a Danish modiﬁed version (only 15 words were read for a total of four times) of
the Rey Auditory Verbal Learning Test [37], the Symbol Digit Modalities Test (90-s
writing test) [38], and Conners’ Continuous Performance Test II (Multi-Health
Systems, Toronto, Canada).
Physical capacity assessed by a ﬁtness test
VO2maxwas determined using a standard progressive exercise test on a bicycle
ergometer (Monark 839 E, Monark Ltd, Varberg, Sweden). Study participants star-
tedwith a 5-minwarm-up at aworkload calculated frombodyweight and expected
V02 max, followed by resistance increase inworkload every minute until they were
unable to maintain a cadence on 60 rpm, VO2 reached a plateau, or the respiratory
exchange ratios were >1.1. VO2 was continuously measured by indirect calorimetry
(Quark b2, Cosmed, Rome, Italy). Before study test days, participants performed a
VO2 max ﬁtness test at screening day for habituation of the test.
Biochemical assays
The circulating levels of plasma insulin, plasma glucose, plasma cholesterols,
plasma triacylglycerols, plasma alanintransaminase (ALAT), plasma thyroid
hormones, and glycosylated hemoglobin (HbA1c) in blood were measured using
standard techniques at the Department of Clinical Biochemistry, Rigshospitalet
University Hospital, Copenhagen, Denmark. Plasma leptin, plasma adiponectin,
plasma interleukin (IL)-6, plasma IL-10, and plasma tumor necrosis factor (TNF)-a
levels were measured using Meso Scale Discovery (MSD) electro-
chemiluminescence (Meso Scale Discovery, Gaithersburg, MD, USA). Serum
cortisol was determined by enzyme immunoassay (R&D Systems, Minneapolis,
MN, USA). All samples were run in duplicates and the means were calculated.
Tests within the control period (T1 and T2) and within the RIF period (T3 and T4)
(2- point measurements)
Physical activity level by Actiheart and pedometer
Participants’ physical activity was assessed by an Actiheart combined heart
rate and uniaxial accelerometers monitor that estimates energy expenditure
above rest. The Actiheart consists of two sensors linked by a cord and was
positioned horizontally on the left chest wall, one sensor at the fourth inter-
costal room and the other sensorw10 cm away. The two component parts were
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Bio Protech Inc.) and worn both night and day except while bathing. A
pedometer was worn attached to the participant’s waistband during waking
hours (except while bathing), and the pedometer was reset to zero each evening
after the daily steps were recorded in a log provided. The mean number of steps
registered on the least active single day (minimum) and the mean number of
steps registered on the most active single day (maximum) were calculated for
each of the participants in the four periods. To adjust for within-week variation
in physical activity the total mean steps and Actiheart outcome for each
participant were weighted with ﬁve of seven and two of seven for weekdays and
weekend days, respectively.
Caloric intake
Study participants recorded their dietary intake in detail using a kitchen scale
via the Internet for 3 d (2 weekdays and 1 weekend day) ﬁve times (in the
screening period and at T1, T2, T3, and T4).
Monitoring of appetite and mood
Participants completed 6 questions regarding appetite on a validated appetite
visual analog scale (VAS) and 13 questions regardingmood on a 7-pointmood scale.
The appetite VAS score consisted of 100-mm lines, and participants were
asked to make a vertical mark across the line corresponding to their feelings
from 0 (not at all) to 100 (extremely) for hunger, satiety, thirst, nausea,Table 1
Descriptive data and laboratory variables in the 10 study participants
Baseline Control D
Descriptive data
Age, y 25.2 (22.2–28.2) –
Total body mass, kg 72.7 (67.8–77.6) 0.6 (0.6 to
Systolic blood pressure, mm Hg* 125.4 (117.9–132.8) 1.4 (5 to 7
Diastolic blood pressure, mm Hg* 71.3 (65.9–76.6) 2.7 (6.9 to
VO2 max, mL$min$kg1* 49.2 (46.8–51.6) 0.5 (2.4 to
DXA scan
Lean body mass, kg 58.9 (54.4–63.4) 0.4 (0.5 to
Total fat mass, % 15.2 (12.1–18.3) 0.1 (0.8 to
Gynoid fat mass, % 20.6 (17.1–24.1) 0.2 (0.8 to
Android fat mass, % 21.3 (17–25.7) 0.0 (1.8 to
Oral glucose tolerance test
Fasting glucose, mmol/L 4.6 (4.3–4.9) 0.3 (0.1 to
Fasting insulin, mmol/L 37.8 (24.2–51.4) 8.1 (23.3
Matsuda Index* 26.9 (19.8–34) 3.3 (9.3 to
HOMA-IR 1.1 (0.8–1.5) 0.1 (0.6 to
Biochemistry
HbA1c, mmol/mol* 32.8 (30.3–35.3) 1.1 (2.4 to
Total cholesterol, mmol/L 4.1 (3.5–4.6) 0 (0.4 to
HDL cholesterol, mmol/L 1.4 (1.2–1.6) 0 (0–0.1)
LDL cholesterol, mmol/L 2.3 (1.9–2.7) 0 (0.3 to
Triacylglycerol, mmol/L 0.7 (0.5–0.9) 0.2 (0–0.5)
Alanintransaminase, U/L* 20.9 (15.5–26.3) 4.6 (1.5 to
Thyrotropin, 10 E–3/L 2 (1.5–2.6) 0.2 (0.2 to
Triiodthyronin, nmol/L 2 (1.8–2.1) 0.2 (0.3 to
Cortisol, ng/Ly 73.7 (52.2–95.3) 25.1 (0.8 to
TNF-a* 4.6 (4.1–5.1) 0.4 (0.4 to
IL-6* 0.3 (0.2–0.4) 0.1 (0.1 to
IL-10* 2.8 (2.1–3.5) 0.1 (0.3 to
Adiponectin, pg/mL* 14 406 (11 262–17 551) 2761 (91–543
Leptin, pg/mL* 1434 (499–2369) 997 (916 t
Cognitive tests
Trail Making Test A 22.2 (19.6–24.8) 2.1 (4.6 to
Trail Making Test B 48.5 (41.4–55.6) 4.6 (2.9 to
Symbol 60.4 (56.4–64.4) 1.7 (7.3 to
RAVLT sum 1–3 27.7 (25.3–30.1) 2.3 (2 to 6
RAVLT 4, words after 30 min 9.1 (7.2–11) 1 (0.9 to
CPTII hit reaction time, T score 39.7 (35.9–43.6) 0.8 (1.3 to
CPTII omission, T score 52.3 (29.4–75.2) 0.6 (4.6 to
CPTII commission, T score 51.4 (43.1–59.7) 0 (4.6 to
D difference, difference between the control D and the RIF D; BMI, body mass index;
minus “before control period” values; CPTII, Conner’s Continuous Performance Test II;
high-density lipoprotein; HOMA-IR, homeostasis model assessment-estimated insulin
Verbal Learning Test; RIF, Ramadan model of intermittent fasting; RIF D, D changes (i
Symbol, symbol digit modalities test; TNF, tumor necrosis factor; VO2 max, maximal
Presented as mean (95% CI) and P value assessed by paired Student’s t test
* Only nine participants in this analysis.
y Only seven participants in this analysis.prospective food consumption (i.e., amount of food the participant could eat),
and fullness. The 7-point mood scale consisted of seven circles. Participants were
asked to make a cross in the circle corresponding to their feelings at the time
from 1 (not at all) to 4 (some) to 7 (a lot) for nervous, anxious, blue, annoyed,
fatigued, restless, cheerful, relaxed, tense, unable to concentrate, carefree,
sluggish, and energetic.
Participants completed the questionnaires ﬁve times daily for 3 d (2weekdays
and 1weekend day) during T1, T2, T3, and T4. The ﬁve times during each daywere
just before breakfast, 30 min after breakfast, at 1500 h, just before dinner, and
30 min after dinner.
Continuous Glucose Monitoring System
As previously described [35], the Continuous Glucose Monitoring System
(CGMS; Medtronic Diabetes Inc.) consisted of the iPro2 recorder and the Guardian
REAL-time CGM, using the same glucose sensor (Enlite Glucose Sensor, Medtronic
Diabetes Inc.). The glucose sensor was inserted just under the skin of the lower
part of the abdomen in a painless procedure and covered with a supplied trans-
parent dressing (Tegaderm HP, 3 M Health Care, St. Paul, MN, USA). Participants
measured a calibrating blood sugar 1 h after insertion, and subsequently four
times daily over 5 d (duration of sensor), using a blood sugar apparatus (Contour,
Bayer HealthCare, Tarrytown, NY, USA). Data for analysis were matched for each
participant in number of hours and of days (including weekdays and weekendRIF D D difference D P value
– –
1.8) 1.1 (2 to 0.2) 1.7 (0–3.3) 0.050
.7) 1.2 (5.7 to 3.3) 2.6 (7.1 to 12.4) 0.55
1.4) 1.8 (8.8) 4.5 (14.5 to 5.5) 0.33
1.5) 0.6 (1.7 to 2.9) 1 (4.2 to 2.1) 0.46
1.2) 1 (1.8 to 0.1) 1.3 (0.3 to 2.9) 0.09
1.0) 0.1 (0.8 to 0.8) 0.1 (1.1 to 1.4) 0.82
0.5) 0 (1 to 1) 0.1 (1.4 to 1.2) 0.84
1.8) 0.4 (1.7 to 0.9) 0.3 (1.8 to 2.5) 0.73
0.6) 0.3 (0–0.5) 0 (0.4 to 0.5) 0.92
to 7.2) 2 (4.5 to 8.6) 10.1 (28.5 to 8.3) 0.25
2.7) 1 (8.9 to 7) 2.3 (14.8 to 10.2) 0.68
0.3) 0.1 (0.2 to 0.3) 0.2 (0.7 to 0.3) 0.35
0.1) 0.8 (1.6 to 0.1) 0.3 (1.7 to 1.1) 0.59
0.3) 0 (0.4 to 0.5) 0.1 (0.8 to 0.7) 0.83
0 (0.1 to 0.1) 0.1 (0–0.2) 0.20
0.3) 0 (0.3 to 0.3) 0 (0.6 to 0.5) 0.86
0 (0.2 to 0.3) 0.2 (0.3 to 0.6) 0.40
10.6) 4.6 (13.2 to 4.1) 9.1 (5.4 to 23.6) 0.19
0.5) 0.1 (0.6 to 0.4) 0.3 (0.4 to 1) 0.37
0) 0.1 (0.2 to 0.1) 0.1 (0.3 to 0.2) 0.57
51) 8.4 (32.6 to 15.7) 33.5 (8 to 75) 0.10
1.1) 0.2 (0.8 to 0.3) 0.6 (0.7 to 1.9) 0.32
0.2) 0 (0.1 to 0.1) 0 (0.2 to 0.2) 0.95
0.5) 0.2 (0.6 to 0.3) 0.3 (0.4 to 1.0) 0.41
1) 980 (4324 to 2364) 3741 (2092 to 9574) 0.18
o 2910) 604 (2762 to 3971) 392 (4694 to 5478) 0.86
0.4) 0.2 (2.5 to 2.9) 2.3 (6.3 to 1.7) 0.22
12.1) 3.5 (17.2 to 10.2) 8.1 (9.8 to 26) 0.33
3.9) 0.3 (5.5 to 6.1) 2.0 (11 to 7) 0.63
.6) 1.5 (1.1 to 4.1) 0.8 (4.9 to 6.5) 0.76
2.9) 0.4 (1.4 to 2.2) 0.6 (2.5 to 3.7) 0.68
2.9) 0.3 (1.9 to 2.5) 0.5 (2.5 to 3.4) 0.72
3.4) 2.1 (10.2 to 6) 1.5 (3.4 to 6.4) 0.50
4.4) 0.5 (3.2 to 4.2) 0.5 (6.8 to 5.7) 0.85
Control D, D changes (control period effect) calculated by “after control period”
DXA, dual-energy x-ray absorptiometry; HbA1c, glycosylated hemoglobin; HDL,
resistance; IL, interleukin; LDL, low-density lipoprotein; RAVLT, the Rey Auditory
ntervention effect) calculated by “after RIF” minus “after control period” values;
oxygen intake
N. M. Harder-Lauridsen et al. / Nutrition 37 (2017) 92–10396days) within and between the study periods (giving a total of 72 h for each of the
periods T1–T4). Days missing >3 h and with less than two calibrating blood
sugars were excluded. Hypo- and hyperglycemic episodeswere deﬁned as a blood
glucose levels <3.3 mmol/L and >11.1 mmol/l, respectively.
Statistical analysis
All analyses were performed as complete-case analyses. A D change for the
control period (BCP  ACP) and for the RIF period (AIF  ACP) were calculated.
The intervention (RIF period) effect was deﬁned as the difference between the
absolute change of the dependent variables between the control period and the
RIF period (i.e., the difference between D changes between ACP and BCP and
between AIF and ACP). These differences were compared with paired Student’s t
tests. For the four time measurements (T1–T4), within-period differences were
evaluated with paired Student’s t tests. Data within each period was pooled as no
differences were found, i.e., values from T1 and T2 are pooled as within the
control period and T3 and T4 values are pooled as within the RIF period. Paired
Student’s t tests were performed between the control and RIF periods. Outcomes
were not corrected for multiple testing as outcomes besides primary (i.e., tests on
BCP, ACP, and AIF days) was regarded as corroborating outcome. Data are
presented as mean  95% conﬁdence interval (CI) and the signiﬁcance level was
set accepted as P < 0.05 (two-tailed). Data analyses were performed using
Stata13 (StataCorp, College Station, TX, USA).Fig. 2. Glucose metabolism measured by oral glucose tolerance test. The area under cur
period (BCP), after the control period (ACP), and after the RIF period (AIF), whereas D cha
for plasma glucose (A) and plasma insulin (B), respectively. P value is assessed by paired
under the curve; RIF, Ramadan model of intermittent fasting.Results
Participants
Ten healthy lean men participated in, and completed, this
nonrandomized, crossover, intervention study (Table 1). They all
had normal medical examinations and normal blood screens
during all three test modules (BCP, ACP, and AIF) examining for
diabetes as well as thyroid, liver, kidney, respiratory, cardiovas-
cular, and hematologic diseases (data not shown).
Anthropometric assessment and blood pressure measurements
Total body weight (Table 1) as well as BMI (at baseline:
22.5 kg/m2, 95% CI, 21.2–23.7) were slightly but signiﬁcantly
different between the control period (control D; 0.2 kg/m2; 95%
CI, 0.2 to 0.5) and the RIF period (RIF D; 0.3 kg/m2; 95% CI,
0.6 to 0.1; P < 0.05). Waist-to-hip ratio (at baseline: 0.9, 95%
CI, 0.8–0.9) did not differ between the control period (controlve is shown as individual plots (n ¼ 9) at the three time points; before the control
nges (i.e., between ACP and BCP and between AIF and ACP) are shown as bar graphs
Student’s t test (and SEM as error bars on bar graphs). NS, not signiﬁcant. AUC, area
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0.0–0.0; P ¼ 0.42). Blood pressure changes also did not differ
between periods (Table 1).
Body composition measured by DXA and MRI scans
Therewas no difference betweenD changeswith regard to total
fat mass, gynoid or android fat mass, or total lean body mass (DXA
results;Table1).Also,MRI scansdidnotdemonstrateadifference for
totalvisceral fatmassdeterminedbefore (990mL,95%CI,579–1340)
and after the RIF period (979 mL; 95% CI, 535–1423; P¼ 0.84).
Standardized OGTT
There was neither a difference between changes in the two
periods in fasting plasma glucose and insulin (Table 1) nor in the
area under curve (AUC) for glucose and insulin during the OGTT
(Fig. 2). The insulin sensitivity determined byMatsuda index and
HOMA-IR also showed no differences between changes in the
two periods (Table 1).
Cognitive function testing
No differences were observed between changes in perfor-
mance of memory, executive functions, and attention in the two
periods (Table 1).
Biochemical assays and physical capacity assessed by ﬁtness test
There were no signiﬁcant differences between changes in the
two periods with regard to HbA1c in blood, cortisol in serum,Table 2
Variables from the study days within the control period (T1 and T2) and the 14-h Ra
Control period
Energy expenditure
Pedometer
Mean weighted steps/d 10 570 (8330–12 811)
Mean minimum steps/d 5566 (3955–7177)
Mean maximum steps/d 16 039 (12 723–19 355
Actiheart
TEE, kJ 12 943 (11 508–14 379
REE, kJ 7396 (7041–7752)
AEE, kJ 4253 (3163–5342)
Sedentary min, <1 MET 1040 (963–1117)
Light min, 1.5–2.9 MET 282.4 (231–334)
Moderate min, 3–5.9 MET 94.7 (69–121)
Vigorous min, >6 MET 19.3 (11–28)
Energy intake*
Total energy, kJ 10 912 (9090–12 735)
Carbohydrate, kJ 3657 (1787–5526)
Fat, kJ 2761 (2158–3364)
Protein, kJ 1704 (1398–2010)
Protein/body weight, g/kg 1.4 (1.2–1.6)
CGMS
Mean BG, mmol/L 5.1 (4.8–5.3)
Min BG, mmol/L 2.8 (2.5–3.2)
Max BG, mmol/L 8.5 (7.3–9.8)
Coefﬁcient of variation, % 18.3 (13.1–23.5)
Mean BG (mmol/L) 1400 h–1700 h 5.1 (4.8–5.4)
Min BG (mmol/L) 1400 h–1700 h 3.5 (3.1–3.8)
Max BG (mmol/L) 1400 h–1700 h 7.5 (6.5–8.6)
AEE, activity energy expenditure; AUC, area under curve; BG, blood glucose; CGMS,
energy expenditure; RIF, Ramadan model of intermittent fasting; TEE, total energy ex
Presented as mean (95% CI) and P value assessed by paired Student’s t test
Control period: pooled data from T1 and T2; RIF period: pooled data from T3 and T4; on
of the lowest/highest blood glucose measured in the time period
* Only nine participants completed the dietary monitoring.plasma ALAT, plasma thyroid hormones, plasma lipid levels, and
in plasma levels of leptin, adiponectin, IL-6 and IL-10, and TNF-a
(Table 1). The same was observed for physical capacity (Table 1).
Physical activity by Actiheart and pedometer
Mean number of steps per day were slightly lower in the RIF
period than in the control period (Table 2). This ﬁnding was not
supported by the habitual physical activity monitored by
Actiheart, which did not show any differences in any aspects
between two periods (Table 2).
Caloric intake and appetite
There were no differences in total caloric or macronutrient
intake between the two periods (Table 2).
The total AUC during the monitoring days (T1–T6) presented
higher peaks for prandial hunger, thirst, and prospective food
consumption scores in the RIF period than in the control period
(Fig. 3A–C). In contrast, lower nadirs were observed in the RIF
period than in the control period for prandial satiety and
(marginally signiﬁcantly for) fullness scores (AUC fullness for
control: 32 398 mm/min, 95% CI, 23 258–41 537 and AUC fullness
forRIF:26337mm/min,95%CI,19985–32688;P¼0.07; Fig. 3D, F).
Looking at the mean appetite response in the late afternoon
(1500 h), hunger, thirst, and prospective food consumption were
higher; satiety and fullness were lower in the RIF fasting than in
the control period (Fig. 3). As participants had been fasting for
several hours at this time point, this was expected. No differ-
ences were found in nausea scores between the two periods
(Fig. 3E).madan model of intermittent fasting period (T3 and T4), n ¼ 10
RIF period P value
9376 (7162–11 590) 0.045
4685 (3405–5965) 0.23
) 15 001 (11 046–18 957) 0.46
) 12 949 (11 499–14 399) 0.98
7391 (7001–7781) 0.85
4263 (3247–5278) 0.97
1027 (940–1114) 0.73
299.9 (223–377) 0.60
98.6 (74–123) 0.69
18 (7–29) 0.72
9965 (7102–12 828) 0.31
3536 (1138–5934) 0.80
2768 (2069–3467) 0.98
1524 (1181–1867) 0.19
1.2 (0.9–1.5) 0.23
5.0 (4.7–5.3) 0.37
3.0 (2.6–3.4) 0.47
8.4 (7.4–9.4) 0.70
16.4 (13.3–19.5) 0.17
4.9 (4.5–5.2) 0.08
3.5 (3.2–3.8) 0.80
6.7 (5.6–7.9) 0.058
continuous glucose monitoring system; MET, metabolic equivalent; REE, resting
penditure
e MET deﬁned as 3.5 mL O2/kg body weight per minute; min/max BG is the mean
Fig. 3. Appetite score differences assessed by VAS satiety questionnaire. Participants completed VAS questionnaires twice (each time 2weekdays and 1weekend day) within the
control period and twicewithin theRIFperiod (n¼ 10, total of 60dper period) todetermine appetite scores. Theﬁgures show themeanVAS response inmm(SEMas error bars) for
before breakfast, 30min after breakfast, at 1500 h, before dinner, and30min after dinnerwith area under curve (AUC) as bar graphs of the six appetite scores: (A) hunger, (B) thirst,
(C) prospective foodconsumption (PFC; i.e., amountof food theparticipant could eat), (D) satiety, (E) nausea, and (F) fullness.Data are presentedasmeans SE. Paired t tests on the
AUCshowed theRIFperiod increasedpostprandialhunger, thirst, andPFCanddecreasedpostprandial satietyand (marginally signiﬁcant;P¼0.07) fullness.Afterapproximately6h
fasting (at 1500 h) during the RIF period, participants also showed increased hunger, thirst, and PFC, and decreased satiety and fullness comparedwith the control period. NS, not
signiﬁcant; RIF, Ramadan model of intermittent fasting; VAS, visual analog scale. *P < 0.05. **P < 0.01. No difference where found in nausea scores.
N. M. Harder-Lauridsen et al. / Nutrition 37 (2017) 92–10398
Fig. 3. (continued).
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The total means of prandial mood response (difference
between pre- and 30-min postprandial score for breakfast and
dinner) for each feeling was calculated from the 7-point mood
scale, to look at possible mood changes if any variation in blood
glucose. No differences were found between the control and RIF
periods. Looking at the prandial response within the meals in
the two periods; pooled pleasant/positive feelings (cheerful,
relaxed, carefree, and energetic) were higher postprandially.
Hence, in the control period, the pooled pleasant/positive feel-
ings were 4.1% preprandially (95% CI, 3.4–4.7) versus 4.6%
postprandially (95% CI, 4–5.2; P ¼ 0.004). Within the RIF period
the pooled pleasant/positive feelings were 3.8% preprandially
(95% CI, 3–4.6) versus 4.3% postprandially (95% CI, 3.5–5.2;
P ¼ 0.007). At the same time, the unpleasant/negative feelings
(nervous, anxious, blue, annoyed, fatigued, restless, tense,
unable to concentrate, and sluggish) were lower postprandially.
Hence, during the control period, the pooled unpleasant/nega-
tive feelings were 2.2% preprandially (95% CI, 1.9–2.6) versus
1.8% postprandially (95% CI, 1.5–2.1; P ¼ 0.0007). Within the RIF
period the pooled unpleasant/negative feelings were 2.1% pre-
prandially (95% CI, 1.6–2.6) versus 1.7% postprandially (95% CI,
1.2–2.3; P ¼ 0.0005), with no observed difference between the
two periods (data not shown). At 1500, the above-mentioned
pooled pleasant/positive feelings were lower during the RIF
period (P < 0.01; Fig. 4B).
The CGMS
There were no differences between the two periods with
regard to overall mean blood glucose and coefﬁcient of variability
(glycemic variability; Table 2). The blood glucose measured with
CGMS in the afternoon (between 1400 h and 1700 h) trended
toward lower mean blood glucose (5.1 mmol/L in the control
period, 95% CI, 4.8–5.4 versus 4.9 mmol/L in the RIF period, 95%
CI, 4.5–5.2; P ¼ 0.08; Fig. 4A). Furthermore, lower glycemic
variability (17.6% in the control period, 95% CI, 12.1–23.1 versus
13.9% in the RIF period, 95% CI, 9.6–18.2; P ¼ 0.06; Fig. 4A), and
lower maximum blood glucose (P ¼ 0.06; Table 2) in the RIF
period compared with the control period.
None of the 10 participants experienced hyperglycemic
episodes at any time during the control or RIF periods of
measurement and there were no differences in the number of
hypoglycemic periods between the two periods (data not shown).
Discussion
We presented data from a comprehensive, nonrandomized,
crossover, intervention studyon the effects of 28 d of 14 h of RIF. In
essence, we found very few differences between 28-d periods of
RIFandcontrol.Despite amodest decrease inbodyweight andBMI
and amore pronounced hunger feeling accompanied by a reduced
satiety sensation, as well as less positive state of mind during theFig. 4. Afternoon glycemic response and state ofmindmeasured by CGMS between 1400
woreCGMS twice during eachperiod as a control for hyper- andhypoglycemic periods (59 d
mean blood glucose between 1400 h and 1700 hwith SEM as error bars. Right side y axis sh
hence, a trend toward lower glucose variability during the afternoon of the RIF period. The 7
and RIF periods (60 d). Themood scale consisted of seven circles. Participantswere asked to
diverse feelings theywere experiencing at the time. Thedata showedare (B) totalmean scor
as error bars on bar graphs). Pleasant/positive feelings (cheerful, relaxed, carefree, and en
restless, tense, unable to concentrate, and sluggish) are pooled in the right end of the bar gra
compared with the control period. CGMS, continuous glucose monitoring system; CV, coeafternoonduring the RIF period comparedwith the control period,
we did not observe any other changes in any of the evaluated
parameters. Altogether, the major ﬁndings of this study indicate
that 28 d of RIF in healthy, lean, ﬁt men do not have an effect on
bodycomposition, glucosehomeostasis, orcognitiveperformance.
Our results are partly supported by other studies that found
weight maintenance in lean participants after IF [9,39–42]. The
conﬂicting evidence regarding the effects of meal frequency on a
number of parameters can be due to several reasons. First, it is
essential to remember that the composition of meals (whether
carbohydrate-, fat-, or protein-rich) may be of importance [43].
Second, physiological changes that can be measured only after
several hours (and days) of fasting can lead to conﬂicting results
[22,29]. Third, the use of different terminology, study designs,
and study groups may inﬂuence conclusions [5].
The primary ﬁndings in the present study may be explained
by a steadiness in body composition (i.e., total fat mass, total
visceral fat mass, and total lean mass) sustained by a balance in
total energy intake (measured by dietary monitoring) and total
energy expenditure (measured by Actiheart accelerometer)
throughout the study period. Hence, the participants managed to
compensate for the lower meal frequency by keeping their
overall energy intake in balance. In the abundant different meal
frequency studies with diverse health ﬁndings in healthy
humans, the majority found a signiﬁcant reduction or increase in
total body weight after an IF [11,20]. The independent effect of
weight loss due to dietary restriction, exercise, or a combination
of the two has been shown in studies to increase positive out-
comes in glucose homeostasis, which could also explain the
diverse ﬁndings in meal frequency studies [27].
Fasting glucose, AUC glucose, and the insulin sensitivity
measured byMatsuda index and HOMA-IR from the OGTT had no
difference in D changes between the two periods. The effect of IF
on the glucose metabolism is also disputed, but one recent
review supports our ﬁndings of no overall effect on glucose
homeostasis [20].
Our CGMS data strongly suggest that the nescience in the lay
press of one being subjected to a low blood sugar/hypoglycemia
leading to mental and physical fatigue in the afternoon (here
measured between 1400 h and 1700 h), cannot be accounted for
by hypoglycemia in ﬁt lean men, as there were no differences at
all in hypoglycemic periods between the two periods. Further-
more, the CGMS data propose (all marginally signiﬁcantly) lower
glucose variability and lower mean, andmaximum blood glucose
in the afternoon hours during the RIF period. These data also
indicate that the participants were truly fasting and further
underscores that stable blood glucose can be maintained during
fasting in healthy lean men [44].
IF studies in animals have shown improvements in cognitive
functions, but human studies are lacking [10]. Although our
cognitive tests included several functions (memory, executive
functions, and attention), none were inﬂuenced by the RIF
period. This is in coherence with the rest of our study results, but
need to be conﬁrmed by others.h and 1700 h and by 7-pointmood scale at 1500 h, respectively. Participants (N¼ 10)
for the control period and59d for the RIF period). (A) The data illustrated are the total
ows coefﬁcient of variability in percent for the time period 1400 h to 1700 h (P¼ 0.06),
-pointmood scaleswere completedﬁve times daily over 3 d during the control (60 d)
make a cross in the circle corresponding from1 (not at all) to 4 (some) to 7 (a lot) to 13
es for each feeling in eachperiod andPvalue is assessedbypairedStudent’s t test (SEM
ergetic) and unpleasant/negative feelings (nervous, anxious, blue, annoyed, fatigued,
ph, showing a decrease in the pooled positive feelings at 1500 h during the RIF period
fﬁcient of variability; RIF, Ramadan model of intermittent fasting. *P < 0.01.
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diture (by Actiheart and pedometer). There was a slight decrease
in mean steps per day during both periods, but this decrease was
slightly more pronounced during the RIF period. Because the
decrease in mean steps was neither supported by Actiheart (or
corrected for multiple testing) nor by any change in VO2 max
ﬁtness test, we interpret this (and especially the slightly
nonsigniﬁcant decrease in energy intake) as a plausible moni-
toring exhaustion [45], or simply change of physical activity (i.e.,
biking is not registered with the pedometer). The observed
marginal decrease in body weight D changes between the
control and RIF periodsmay reﬂect the observed increase in body
weight during the control period, giving a total balanced body
weight from start to end of the whole study period. An alterna-
tive explanation could be a small dehydration (i.e., the partici-
pants abstained from drinking any ﬂuids) supported by a
nonsigniﬁcant decrease in lean body mass measured by DXA
scan. Although the relative weight loss during RIF was not
clinically relevant, the possibility exists that RIF over long periods
may contribute to maintain a stable low body weight.
A wide range of blood samples (including blood lipids,
inﬂammation, adipokines, and thyroid hormones) supported the
primary lack of effect of the RIF period on metabolic and
physiologic parameters in the present study. Biochemically,
fasting leads to an activation of metabolic mechanisms designed
to preserve carbohydrates and increase the dependence on
energy produced by themetabolism of fat, which typically occurs
after 10 to 12 h of fasting [11]. According to our results, it appears
that this shift to ketone bodies during lipid metabolism is safe
and does not inﬂuence the observed health indicators in lean
participants.
The higher ﬂuctuation in appetite sensation (Fig. 3) during the
RIF period provides further evidence to the greater peaks and
deeper nadirs in appetite sensation, glucose, insulin, and ghrelin
found in studies comparing low meal frequency studies to high
meal frequency [2,39], although an overall higher AUC hunger and
lower AUC satiety sensation were found in the present study in
contrast toﬁndingbyMunsters andSaris [39]. This couldbedue toa
longer study period and a self-regulation of size, time, and
compositionofmeals in thepresent study.Ourresults suggesta lack
of habituation to the 28 d of fasting in appetite sensation, which
may be necessary to regulate energy intake to maintainweight.
For practical reasons, the mood score test was located at the
same time points (prandial and at 1500 h) as the satiety ques-
tions. Some studies ﬁnd an improvement in mood disorders
during prolonged (>8 d) fasting with a caloric restriction [46],
whereas mood has been found decreased in participants of the
Ramadan and women in an IF study [29,47]. In the present study,
the pooled positive feelings showed a surprising decrease at
1500 h during the RIF period compared with the control period.
Postprandially, during both periods, the participants perceived
an increase in pooled positive feelings and a decrease in pooled
negative feelings. The presented prandial change in mood is
probably experienced as part of the rewarding effects of food
intake through the dopaminergic reward system [48], whereas
the improvement in mood disorders found during prolonged
could be due to the serotonergic system [46]. Thus, the decrease
in positive feelings during the afternoon in the RIF period
corresponds well with the fact that the participants were eating
during the afternoon in the control period and thus had an
increase in pleasant/positive feelings postprandially compared
with the afternoon during the RIF period, when they were fast-
ing. To our knowledge, few studies have explored the effects on
mood (and cognitive functions) during the ﬂuctuations inhydration of the Ramadan fasting, which also may explain the
more negative feelings [33].Limitations
A randomization of the crossover design would have been
preferable with regard to any effect on outcome from different
seasons or the likely decrease in monitoring compliance found
during the RIF period. However, we considered that weight loss
or altered beneﬁcial eating habits introduced by the RIF before
the control period would introduce an even more pronounced
bias. To prevent seasonal inﬂuence the participants were over-
lapping for the period of 10 mo (i.e., while one participant was in
the control period another was in the RIF period). Although
several human studies with positive effects from IF are carried
out for long-term periods (10–12 mo), some effect from fasting is
normally found after 2 to 4 wk [23,27,29]. Obviously, the present
data do not exclude the possibility that IF would affect other
populations differently (e.g., elderly, women, obese, or
individuals who are insulin resistant).Conclusions
Free-living participants were able to comply with 14 h of daily
daylight abstinence from food and drinking for 28 d without any
effects on body composition, glucose metabolism, and cognitive
function. This suggests that meal frequency may not be as
important as overall energy intake with regard to metabolic
ﬂexibility in healthy lean males.Acknowledgments
The authors acknowledge the study participants for their
involvement throughout tedious study days. They acknowledge
Hanne Villumsen, Ruth Rousing, Dean Tuladhar, and Louise Seier
Hansen for their technical assistance. The authors also acknowl-
edge Kristian Karstoft, Lene Theil Skovgaard, Erik Johnson, and
Thomas P. Solomon their advice.References[1] Hall KD, Heymsﬁeld SB, Kemnitz JW, Klein S, Schoeller DA, Speakman JR.
Energy balance and its components: Implications for body weight regulation.
Am J Clin Nutr 2012;95:989–94.
[2] Solomon TP, Chambers ES, Jeukendrup AE, Toogood AA, Blannin AK. The
effect of feeding frequency on insulin and ghrelin responses in human
subject. Br J Nutr 2008;100:810–9.
[3] Mattson MP. The need for controlled studies of the effects of meal
frequency on health. Lancet 2005;365:1978–80.
[4] Ma Y, Bertone ER, Stanek EJ, Reed GW, Hebert JR, Cohen NL, et al. Association
between eating patterns and obesity in a free-living US adult population. Am
J Epidemiol 2003;158:85–92.
[5] Huseinovic E, Winkvist A, Slimani N, Park M, Freisling H, Boeing H, et al.
Meal patterns across ten European countries – results from the European
Prospective Investigation into Cancer and Nutrition (EPIC) calibration
study. Public Health Nutr 2016;19:2769–80.
[6] Leidy H, Campbell W. The effect of eating frequency on appetite control and
food intake: brief synopsis of controlled feeding studies. J Nutr
2011;141:154S–7S.
[7] The Danish Food Administration, DTU National Food Institute, and The
Danish Health Authority, Anbefalinger for den danske institutionskost
[Recommendations for the diet in Danish institutions], Komiteen for Sund-
hedsoplysning (TheDanishCommittee forHealthEducation), 2015.Available
at: http://altomkost.dk/publikationer/publikation/pub/hent-ﬁl/publication/
anbefalinger-for-den-danske-institutionskost/. Accessed August 6, 2016.
[8] Berteus Forslund H, Torgerson JS, Sjöström L, Lindroos AK. Snacking
frequency in relation to energy intake and food choices in obese men and
women compared to a reference population. Int J Obes 2005;29:711–9.
N. M. Harder-Lauridsen et al. / Nutrition 37 (2017) 92–103 103[9] Betts JA, Richardson JD, Chowdhury EA, Holman GD, Tsintzas K,
Thompson D. The causal role of breakfast in energy balance and health: A
randomized controlled trial in lean adults. Am J Clin Nutr 2014;100:539–47.
[10] Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical
applications. Cell Metab 2014;19:181–92.
[11] Mattson MP, Allison DB, Fontana L, Harvie M, Longo VD, Malaisse WJ, et al.
Meal frequency and timing in health and disease. Proc Natl Acad Sci U S A
2014;111:16647–53.
[12] Seimon R, Roekenes J, Zibellini J, Zhu B, Gibson A, Hills A, et al. Do inter-
mittent diets provide physiological beneﬁts over continuous diets for
weight loss? A systematic review of clinical trials. Mol Cell Endocrinol
2015;418:153–72.
[13] Al-Shafei AIM. Ramadan fasting ameliorates arterial pulse pressure and
lipid proﬁle, and alleviates oxidative stress in hypertensive patients. Blood
Press 2014;23:160–7.
[14] Goldhamer A, Lisle D, Parpia B, Anderson SV, Campbell TC. Medically
supervised water-only fasting in the treatment of hypertension. J
Manipulative Physiol Ther 2001;24:335–9.
[15] Johnson JB, Summer W, Cutler RG, Martin B, Hyun DH, Dixit VD, et al.
Alternate day calorie restriction improves clinical ﬁndings and reduces
markers of oxidative stress and inﬂammation in overweight adults with
moderate asthma. Free Radic Biol Med 2007;42:665–74.
[16] Müller H, de Toledo FW, Resch KL. Fasting followed by vegetarian diet in
patients with rheumatoid arthritis: a systematic review. Scand J Rheumatol
2001;30:1–10.
[17] Kjeldsen-Kragh J, Haugen M, Borchgrevink C, Laerum E, Eek M, Mowinkel P,
et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid
arthritis. Lancet 1991;338:899–902.
[18] Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon D, Evans G, et al. The
effects of intermittent or continuous energy restriction on weight loss and
metabolic disease risk markers: A randomized trial in young overweight
women. Int J Obes 2011;35:714–27.
[19] Harvie M, Wright C, Pegington M, Mcmullan D, Mitchell E, Martin B, et al.
The effect of intermittent energy and carbohydrate restriction v. daily
energy restriction on weight loss and metabolic disease risk markers in
overweight women. Br J Nutr 2013;110:1534–47.
[20] Varady KA. Impact of intermittent fasting on glucose homeostasis. Curr
Opin Clin Nutr Metab Care 2016;19:300–2.
[21] Betts JA, Thompson D, Richardson JD, Chowdhury EA, Jeans M, Holman GD,
et al.BathBreakfast Project (BBP)–examining the roleof extendeddaily fasting
inhumanenergybalanceandassociatedhealthoutcomes: studyprotocol fora
randomised controlled trial [ISRCTN31521726]. Trials 2011;12:172.
[22] Trepanowski JF, Bloomer RJ. The impact of religious fasting on human
health. Nutr J 2010;9:57.
[23] Kul S, Savas E, Öztürk Z, Karadag G. Does Ramadan fasting alter body
weight and blood lipids and fasting blood glucose in a healthy population?
A meta-analysis. J Relig Health 2014;53:929–42.
[24] Nematy M, Alinezhad-Namaghi M, Rashed MM, Mozhdehifard M,
Sajjadi SS, Akhlaghi S, et al. Effects of Ramadan fasting on cardiovascular
risk factors: a prospective observational study. Nutr J 2012;11:69.
[25] Kiyani MM, Memon AR, Amjad MI, Ameer MR, Sadiq M, Mahmood T. Study
of human biochemical parameters during and after Ramadan. J Relig
Health 2017;56:55–62.
[26] Vardarl MC, Hammes HP, Vardarli I. Possible metabolic impact of Ramadan
fasting in healthy men. Turk J Med Sci 2014;44:1010–20.
[27] Gnanou JV, Caszo BA, Khalil KM, Abdullah SL, Knight VF, Bidin MZ. Effects of
Ramadan fasting on glucose homeostasis and adiponectin levels in healthy
adult males. J Diabetes Metab Disord 2015;14:55.
[28] Ajabnoor GM, Bahijri S, Borai A, Abdulkhaliq AA, Al-Aama JY, Chrousos GP.
Health impact of fasting in Saudi Arabia during Ramadan: association withdisturbed circadian rhythm and metabolic and sleeping patterns. PLoS One
2014;9:e96500.
[29] Roky R, Iraki L, HajKhlifa R, Lakhdar Ghazal N, Hakkou F. Daytime alertness,
mood, psychomotor performances, and oral temperature during Ramadan
intermittent fasting. Ann Nutr Metab 2000;44:101–7.
[30] Reilly T, Waterhouse J. Altered sleep-wake cycles and food intake: the
Ramadan model. Physiol Behav 2007;90:219–28.
[31] Dolu N, Yüksek A, Sizer A, Alay M. Arousal and continuous attention during
Ramadan intermittent fasting. J Basic Clin Physiol Pharmacol 2007;18:315–22.
[32] BaHammam A, Alrajeh M, Albabtain M, Bahammam S, Sharif M. Circadian
pattern of sleep, energy expenditure, and body temperature of young
healthy men during the intermittent fasting of Ramadan. Appetite
2010;54:426–9.
[33] Cherif A, Roelands B, Meeusen R, Chamari K. Effects of intermittent fasting,
caloric restriction, and Ramadan intermittent fasting on cognitive performance
at rest and during exercise in adults. Sports Med 2016;46:35–47.
[34] Møller JB, Pedersen M, Tanaka H, Ohsugi M, Overgaard RV, Lynge J, et al.
Body composition is the main determinant for the difference in type 2
diabetes pathophysiology between Japanese and caucasians. Diabetes Care
2014;37:796–804.
[35] Harder-Lauridsen NM, Birk NM, Ried-Larsen M, Juul A, Andersen LB,
Pedersen BK, et al. A randomized controlled trial on a multicomponent
intervention for overweight school-aged children – Copenhagen, Denmark.
BMC Pediatr 2014;14:273.
[36] Tombaugh TN. Trail Making Test A and B: normative data stratiﬁed by age
and education. Arch Clin Neuropsychol 2004;19:203–14.
[37] Van der Elst W, van Boxtel MP, Gvan Breukelen GJ, Jolles J. Rey’s verbal
learning test: normative data for 1855 healthy participants aged 24-81
years and the inﬂuence of age, sex, education, and mode of presentation. J
Int Neuropsychol Soc 2005;11:290–302.
[38] Kiely KM, Butterworth P, Watson N, WoodenM. The symbol digit modalities
test: normative data from a large nationally representative sample of
Australians. Arch Clin Neuropsychol 2014;29:767–75.
[39] Munsters MJ, Saris WH. Effects of meal frequency on metabolic proﬁles and
substrate partitioning in lean healthy males. PLoS One 2012;7:e38632.
[40] StoteKS, BaerDJ, SpearsK, PaulDR,HarrisGK, RumplerWV, et al. Acontrolled
trial of reduced meal frequency without caloric restriction in healthy,
normal-weight, middle-aged adults. Am J Clin Nutr 2007;85:981–8.
[41] Yucel A, Degirmenci B, Acar M, Albayrak R, Haktanir A. The effect of fasting
month of Ramadan on the abdominal fat distribution: assessment by
computed tomography. Tohoku J Exp Med 2004;204:179–87.
[42] Soeters MR, Lammers NM, Dubbelhuis PF, Ackermans MT,
Jonkers-schuitema CF, Fliers E, et al. Intermittent fasting does not affect
whole-body glucose, lipid, or protein metabolism. Am J Clin Nutr
2009;90:1244–51.
[43] Holmstrup ME, Cowens CM, Fairchild TJ, Kanaley JA. Effect of meal
frequency on glucose and insulin excursions over the course of a day.
e-SPEN Eur e-Journal Clin Nutr Metab J 2010;5:e277–80.
[44] Standl E, Schnell O, Ceriello A. Postprandial hyperglycemia and glycemic
variability: Should we care? Diabetes Care 2011;34(suppl 2):S120–7.
[45] Bandini LG, Schoeller DA, Cyr HN, Dietz WH. Validity of reported energy
intake in obese and nonobese adolescents. Am J Clin Nutr 1990;52:421–5.
[46] Fond G, Macgregor A, Leboyer M, Michalsen A. Fasting in mood disorders:
Neurobiology and effectiveness. a review of the literature. Psychiatry Res
2013;209:253–8.
[47] Appleton KM, Baker S. Distraction, not hunger, is associated with lower
mood and lower perceived work performance on fast compared to non-fast
days during intermittent fasting. J Health Psychol 2015;20:702–11.
[48] Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food
intake: implications for obesity. Trends Cogn Sci 2011;15:37–46.
